Byrna Technologies (NASDAQ:BYRN), Inc. (NASDAQ: BYRN) designs, develops and markets non-lethal personal security devices and accessories intended to provide an alternative to traditional firearms. The company’s flagship offerings deploy impact projectiles and chemical irritants in a compact, pistol-style form factor. Its product portfolio includes the Byrna SD and Byrna HD launchers, which utilize proprietary kinetic and irritant cartridges, as well as the lightweight Byrna Air, a CO₂-powered variant optimized for close-quarters defense.
In addition to its core self-defense launchers, Byrna Technologies supplies a range of consumables and support products, including cartridges loaded with pepper-based irritants, inert training rounds, holsters, safe-carry cases and speed loaders. The company also provides online and in-person training resources designed to help end users develop safe handling skills, familiarize themselves with device operation and adhere to local regulations. Through its Byrna Law Enforcement Solutions division, it offers tailored equipment packages for police and security agencies seeking less-lethal tools to de-escalate confrontations.
Founded in 2014 and headquartered in Cedar Knolls, New Jersey, Byrna Technologies has grown its distribution network across North America, serving both individual consumers and institutional clients. In April 2021, the company completed a business combination with a special purpose acquisition vehicle, enabling it to begin trading on the NASDAQ under the symbol BYRN. Byrna continues to invest in product development and intellectual property, holding multiple patents for its launch mechanisms and cartridge designs.
With a focus on innovation in non-lethal deterrence, Byrna Technologies aims to expand its market penetration through direct-to-consumer channels, strategic partnerships and international distribution agreements. The company’s non-firearm approach positions it as a potential growth play in the broader self-defense and law enforcement equipment sectors, where demand for less-lethal alternatives has been rising.
